Trevena
TRVN
#11301
Rank
NZ$0.01 M
Marketcap
NZ$0.02138
Share price
0.00%
Change (1 day)
-38.81%
Change (1 year)

Trevena (TRVN) - Total liabilities

Total liabilities on the balance sheet as of September 2024 : NZ$75.72 Million

According to Trevena's latest financial reports the company's total liabilities are NZ$75.72 Million. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Trevena - Total liabilities on balance sheet (from 2012 to 2024)

Total liabilities by year

Year Total liabilities Change
2023-12-31NZ$76.31 M46.47%
2022-12-31NZ$52.1 M129.68%
2021-12-31NZ$22.68 M-30.85%
2020-12-31NZ$32.8 M30.61%
2019-12-31NZ$25.11 M-33.28%
2018-12-31NZ$37.64 M-29.8%
2017-12-31NZ$53.63 M2.98%
2016-12-31NZ$52.07 M10.61%
2015-12-31NZ$47.08 M308.27%
2014-12-31NZ$11.53 M178.61%
2013-12-31NZ$4.13 M-58.1%
2012-12-31NZ$9.87 M93.23%
2011-12-31NZ$5.11 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
Amgen
AMGN
NZ$149.59 B 197,445.71%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
NZ$156.48 B 206,545.17%๐Ÿ‡บ๐Ÿ‡ธ USA
Cytokinetics
CYTK
NZ$3.73 B 4,836.91%๐Ÿ‡บ๐Ÿ‡ธ USA
AcelRx Pharmaceuticals
ACRX
NZ$11.2 M-85.20%๐Ÿ‡บ๐Ÿ‡ธ USA
Cara Therapeutics
CARA
NZ$86.27 M 13.94%๐Ÿ‡บ๐Ÿ‡ธ USA